SES Trademark

Trademark Overview

On Wednesday, May 15, 2024, a trademark application was filed for SES with the United States Patent and Trademark Office. The USPTO has given the SES trademark a serial number of 79398902. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, January 13, 2026. This trademark is owned by Hytest Oy. The SES trademark is filed in the Chemical Products category with the following description:

monoclonal antibody reagents, other than for medical use; monoclonal antibody reagents for diagnostic use not for medical purposes
ses

General Information

Serial Number79398902
Word MarkSES
Filing DateWednesday, May 15, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, January 13, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesmonoclonal antibody reagents, other than for medical use; monoclonal antibody reagents for diagnostic use not for medical purposes

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, July 4, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHytest Oy
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFI

Trademark Events

Event DateEvent Description
Thursday, July 4, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, July 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 10, 2024APPLICATION FILING RECEIPT MAILED
Friday, November 29, 2024ASSIGNED TO EXAMINER
Saturday, November 30, 2024NON-FINAL ACTION WRITTEN
Sunday, December 1, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, December 14, 2024REFUSAL PROCESSED BY MPU
Saturday, December 14, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, January 5, 2025REFUSAL PROCESSED BY IB
Monday, June 9, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 9, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 9, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 16, 2025NON-FINAL ACTION WRITTEN
Friday, August 8, 2025REFUSAL PROCESSED BY IB
Thursday, November 13, 2025NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, December 3, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, December 3, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, December 18, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, January 13, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 13, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 13, 2026TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

medical monoclonal reagents antibody purposes diagnostic other than